Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (588219) 588219
Newspaper Article (27675) 27675
Newsletter (5938) 5938
Book Chapter (5013) 5013
Patent (1685) 1685
Magazine Article (1544) 1544
Book / eBook (1061) 1061
Trade Publication Article (707) 707
Web Resource (414) 414
Conference Proceeding (370) 370
Dissertation (338) 338
Publication (97) 97
Transcript (90) 90
Government Document (89) 89
Reference (55) 55
Book Review (39) 39
Streaming Video (22) 22
Report (19) 19
Journal / eJournal (4) 4
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (474657) 474657
life sciences & biomedicine (411195) 411195
humans (357469) 357469
animals (229498) 229498
proteins (193041) 193041
male (163265) 163265
female (153053) 153053
mice (106778) 106778
biological and medical sciences (93640) 93640
oncology (87570) 87570
middle aged (78761) 78761
medical sciences (77305) 77305
gene expression (74731) 74731
research (71646) 71646
adult (70378) 70378
cancer (69799) 69799
cell biology (64428) 64428
analysis (63954) 63954
apoptosis (62773) 62773
biochemistry & molecular biology (61941) 61941
science & technology - other topics (59061) 59061
research article (57114) 57114
pharmacology & pharmacy (55896) 55896
aged (55858) 55858
multidisciplinary sciences (55343) 55343
health aspects (54988) 54988
medicine (54806) 54806
kinases (51589) 51589
tumors (51367) 51367
signal transduction (48842) 48842
rats (47760) 47760
immunology (46644) 46644
cell line, tumor (45965) 45965
mutation (43536) 43536
science (42290) 42290
rodents (42072) 42072
genetic aspects (41999) 41999
care and treatment (40715) 40715
inflammation (40217) 40217
medicine, research & experimental (39958) 39958
research & experimental medicine (39938) 39938
physiological aspects (39390) 39390
neurosciences (38473) 38473
neurosciences & neurology (37452) 37452
studies (37093) 37093
biology (34998) 34998
disease models, animal (34348) 34348
medical research (32213) 32213
treatment outcome (31861) 31861
abridged index medicus (31225) 31225
chemistry (29481) 29481
pharmacology. drug treatments (29437) 29437
genes (28976) 28976
phosphorylation (28536) 28536
cytokines (28517) 28517
enzymes (28493) 28493
cells, cultured (27832) 27832
mice, inbred c57bl (27799) 27799
protein binding (27712) 27712
stem cells (27228) 27228
fundamental and applied biological sciences. psychology (26447) 26447
cell proliferation (26324) 26324
physical sciences (26159) 26159
biochemistry (26153) 26153
microbiology (26098) 26098
patients (25847) 25847
chemotherapy (25614) 25614
metastasis (25059) 25059
hematology (24951) 24951
immunohistochemistry (24744) 24744
deoxyribonucleic acid--dna (24679) 24679
development and progression (24330) 24330
antineoplastic agents - therapeutic use (24320) 24320
prognosis (23782) 23782
risk factors (23418) 23418
biotechnology & applied microbiology (23161) 23161
physiology (23136) 23136
peptides (23034) 23034
breast cancer (22780) 22780
apoptosis - drug effects (22556) 22556
cancer therapies (22437) 22437
biomarkers (22185) 22185
cell cycle (22168) 22168
cell line (21795) 21795
metabolism (21722) 21722
life sciences (20939) 20939
time factors (20829) 20829
recombinant proteins - therapeutic use (20684) 20684
signal transduction - drug effects (20651) 20651
biotechnology (20429) 20429
lipids (20299) 20299
infectious diseases (20237) 20237
adolescent (19906) 19906
neurology (19748) 19748
rats, sprague-dawley (19669) 19669
clinical trials (19326) 19326
review (19286) 19286
pathology (19266) 19266
oxidative stress (19259) 19259
ligands (19231) 19231
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (410) 410
Online Resources - Online (169) 169
Collection Dvlpm't (Acquisitions) - Vendor file (112) 112
UofT at Mississauga - Stacks (85) 85
Collection Dvlpm't (Acquisitions) - Closed Orders (30) 30
Chemistry (A D Allen) - Stacks (29) 29
UofT at Scarborough - Stacks (19) 19
Engineering & Comp. Sci. - Stacks (17) 17
UTL at Downsview - May be requested (6) 6
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
Robarts - Stacks (3) 3
Earth Sciences (Noranda) - Stacks (2) 2
Gerstein Science - Circulation Desk (2) 2
St. Michael's Hospital - Stacks (2) 2
Aerospace - Stacks (1) 1
Baycrest Hospital - Stacks (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Not Returned (1) 1
Gerstein Science - Periodical Stacks (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Online (1) 1
Online Resources - Pharmacy (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Periodicals (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (622273) 622273
German (3648) 3648
Japanese (3613) 3613
French (2827) 2827
Chinese (2253) 2253
Russian (1766) 1766
Spanish (1406) 1406
Portuguese (751) 751
Italian (626) 626
Polish (519) 519
Norwegian (245) 245
Dutch (227) 227
Hungarian (207) 207
Czech (176) 176
Danish (136) 136
Korean (112) 112
Swedish (83) 83
Ukrainian (76) 76
Finnish (73) 73
Bulgarian (58) 58
Croatian (57) 57
Romanian (56) 56
Serbian (55) 55
Turkish (54) 54
Hebrew (44) 44
Slovak (27) 27
Persian (9) 9
Lithuanian (8) 8
Icelandic (6) 6
Slovenian (5) 5
Arabic (4) 4
Bosnian (4) 4
Urdu (4) 4
Afrikaans (2) 2
Greek (2) 2
Hindi (2) 2
Estonian (1) 1
Faroese (1) 1
Indonesian (1) 1
Latvian (1) 1
Nauru (1) 1
Ndonga (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
by Coiffier, Bertrand and Federico, Massimo and Caballero, Dolores and Dearden, Claire and Morschhauser, Franck and Jäger, Ulrich and Trümper, Lorenz and Zucca, Emanuele and Gomes da Silva, Maria and Pettengell, Ruth and Weidmann, Eckhart and d’Amore, Francesco and Tilly, Hervé and Zinzani, Pier Luigi
Cancer treatment reviews, ISSN 0305-7372, 2014, Volume 40, Issue 9, pp. 1080 - 1088
Hematology, Oncology and Palliative Medicine | Antifolate | Nucleoside analog | Histone deacetylase inhibitor | Fusion protein | Peripheral T-cell lymphoma | Immunomodulatory agent | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Doxorubicin - therapeutic use | Humans | Recombinant Fusion Proteins - therapeutic use | Interleukin-2 - therapeutic use | Neoplasm Recurrence, Local - drug therapy | Antineoplastic Agents - therapeutic use | Cyclophosphamide - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Folic Acid Antagonists - therapeutic use | Stem Cell Transplantation | Topoisomerase Inhibitors - pharmacology | Thalidomide - analogs & derivatives | Diphtheria Toxin - therapeutic use | Topoisomerase Inhibitors - therapeutic use | Immunoconjugates - therapeutic use | Antineoplastic Agents - pharmacology | Depsipeptides - therapeutic use | Prednisolone - therapeutic use | Lymphoma, T-Cell, Peripheral - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Alemtuzumab | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, T-Cell, Peripheral - pathology | Vincristine - therapeutic use | Histone Deacetylase Inhibitors - therapeutic use | Lymphoma, T-Cell, Peripheral - therapy | Thalidomide - therapeutic use | Folic Acid Antagonists - pharmacology | Care and treatment | Lymphomas | T cells | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors‐based therapy
by Sultanik, Philippe and Mallet, Vincent and Lagaye, Sylvie and Casrouge, Armanda and Dorival, Céline and Barthe, Yoann and Fontaine, Hélène and Hézode, Christophe and Mottez, Estelle and Bronowicki, Jean‐Pierre and Carrat, Fabrice and Theodorou, Ioannis and Abel, Laurent and Gayat, Etienne and Fontanet, Arnaud and Pol, Stanislas and Albert, Matthew L and ANRS CO20-CUPIC
Liver international, ISSN 1478-3223, 07/2015, Volume 35, Issue 7, pp. 1833 - 1844
HCV protease inhibitor | virological response | apolipoprotein H | biomarker | chronic hepatitis C | Biomarker | Chronic hepatitis C | Apolipoprotein H | Virological response | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Recombinant Proteins - therapeutic use | Predictive Value of Tests | Prospective Studies | Area Under Curve | Humans | Middle Aged | Hepacivirus - genetics | Male | RNA, Viral - blood | Molecular Targeted Therapy | Polyethylene Glycols - therapeutic use | Viral Load | beta 2-Glycoprotein I - blood | Oligopeptides - therapeutic use | Time Factors | Female | Drug Therapy, Combination | France | Protease Inhibitors - therapeutic use | Hepacivirus - drug effects | Virus Replication - drug effects | Proline - analogs & derivatives | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Treatment Outcome | Biomarkers - blood | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - blood | Proline - therapeutic use | Hepacivirus - enzymology | Hepacivirus - growth & development | ROC Curve | Viral Nonstructural Proteins - metabolism | Aged | Viral Nonstructural Proteins - antagonists & inhibitors | Protease inhibitors | Proteases | Analysis | Liver | Hepatitis C virus | Hepatitis C | Apolipoproteins | Liver cirrhosis | Index Medicus | beta 2-Glycoprotein I/blood | Virus Replication/drug effects | Polyethylene Glycols/therapeutic use | Protease Inhibitors/therapeutic use | Hepatitis C, Chronic/blood | Interferon-alpha/therapeutic use | Life Sciences | Immunology | Hepacivirus/growth & development | Viral Nonstructural Proteins/antagonists & inhibitors | Biomarkers/blood | Hepatitis C, Chronic/drug therapy | Proline/analogs & derivatives | Hepacivirus/enzymology | Hepacivirus/genetics | Proline/therapeutic use | Viral Nonstructural Proteins/metabolism | Recombinant Proteins/therapeutic use | RNA, Viral/blood | Antiviral Agents/therapeutic use | Oligopeptides/therapeutic use | Hepacivirus/drug effects | Hepatitis C, Chronic/diagnosis | Ribavirin/therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Drug treatment of idiopathic pulmonary fibrosis systematic review and network meta-analysis
by Canestaro, William J and Forrester, Sara H and Raghu, Ganesh and Ho, Lawrence and Devine, Beth E
Chest, ISSN 0012-3692, 03/2016, Volume 149, Issue 3, pp. 756 - 766
Epidemiology (pulmonary) | Evidence-based medicine | Idiopathic pulmonary fibrosis | Meta-analysis | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Recombinant Proteins - therapeutic use | Azathioprine - therapeutic use | Interferon-gamma - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Anticoagulants - therapeutic use | Enzyme Inhibitors - therapeutic use | Warfarin - therapeutic use | Vital Capacity | Imatinib Mesylate - therapeutic use | Phenylpropionates - therapeutic use | Sulfonamides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Pyrimidines - therapeutic use | Bayes Theorem | Indoles - therapeutic use | Free Radical Scavengers - therapeutic use | Pyridones - therapeutic use | Acetylcysteine - therapeutic use | Endothelin Receptor Antagonists - therapeutic use | Idiopathic Pulmonary Fibrosis - drug therapy | Pyridazines - therapeutic use | Etanercept - therapeutic use | Treatment outcome | Usage | Pulmonary fibrosis | Drug therapy | Analysis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Reversal of anticoagulants: an overview of current developments
by Greinacher, Andreas and Thiele, Thomas and Selleng, Kathleen
Thrombosis and haemostasis, ISSN 0340-6245, 09/2015, Volume 113, Issue 5, pp. 931 - 942
Review Article | Rivaroxaban | Antidotes | Dabigatran | New anticoagulants | Apixaban | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Recombinant Proteins - therapeutic use | Pyrazoles - therapeutic use | Anticoagulants - administration & dosage | Thrombosis - complications | Humans | Antibodies, Monoclonal - therapeutic use | Heparin - therapeutic use | Hemorrhage - prevention & control | Thiazoles - therapeutic use | Dabigatran - therapeutic use | Vitamin K - antagonists & inhibitors | Benzamides - therapeutic use | Anticoagulants - chemistry | Factor Xa - therapeutic use | Intracranial Hemorrhages - prevention & control | Rivaroxaban - therapeutic use | Pyridines - therapeutic use | Polysaccharides - therapeutic use | Hemostatics - chemistry | Antibodies, Monoclonal, Humanized - therapeutic use | Administration, Oral | Antithrombins - therapeutic use | Infusions, Parenteral | Clinical Trials as Topic | Factor Xa Inhibitors - therapeutic use | Animals | Protamines - therapeutic use | Pyridones - therapeutic use | Thrombosis - drug therapy | Hemorrhage - chemically induced | Hemostatics - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Novel molecular targeted therapies for refractory thyroid cancer
by Perez, Cesar A and Santos, Edgardo S and Arango, Belisario A and Raez, Luis E and Cohen, Ezra E. W and Eisele, David W
Head & neck, ISSN 1043-3074, 05/2012, Volume 34, Issue 5, pp. 736 - 745
epidermal growth factor (EGF) | RET | immunomodulator | vascular disrupting agent | multi‐kinase inhibitor | vascular endothelial growth factor (VEGF) | thyroid cancer | histone acetylation | B‐Raf | heat shock protein (HSP) | multi-kinase inhibitor | B-Raf | Otorhinolaryngology | Life Sciences & Biomedicine | Surgery | Science & Technology | Otorhinolaryngology. Stomatology | Malignant tumors | Pharmacology. Drug treatments | Thyroid. Thyroid axis (diseases) | Biological and medical sciences | Endocrinopathies | Medical sciences | Immunomodulators | Niacinamide - analogs & derivatives | Anilides - therapeutic use | Bibenzyls - therapeutic use | Humans | Antineoplastic Agents - therapeutic use | Benzenesulfonates - therapeutic use | Pyrazines - therapeutic use | Boronic Acids - therapeutic use | Proto-Oncogene Proteins c-kit - antagonists & inhibitors | Thalidomide - analogs & derivatives | Angiogenesis Inhibitors - therapeutic use | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Valproic Acid - therapeutic use | Depsipeptides - therapeutic use | Imidazoles - therapeutic use | Lactams, Macrocyclic - therapeutic use | Pyrroles - therapeutic use | Pyridines - therapeutic use | Bortezomib | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Piperazines - therapeutic use | Imatinib Mesylate | Sulfonamides - therapeutic use | Thyroid Neoplasms - drug therapy | HSP90 Heat-Shock Proteins - antagonists & inhibitors | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Quinazolines - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Hydroxamic Acids - therapeutic use | Indoles - therapeutic use | Histone Deacetylase Inhibitors - therapeutic use | Quinolines - therapeutic use | Benzamides | Thalidomide - therapeutic use | Benzoquinones - therapeutic use | Indazoles - therapeutic use | Protein-Tyrosine Kinases - antagonists & inhibitors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Improvement in Survival End Points of Patients With Metastatic Renal Cell Carcinoma Through Sequential Targeted Therapy
by Calvo, Emiliano and Schmidinger, Manuela and Heng, Daniel Y.C and Grünwald, Viktor and Escudier, Bernard
Cancer treatment reviews, ISSN 0305-7372, 2016, Volume 50, pp. 109 - 117
Hematology, Oncology and Palliative Medicine | Prognostic markers | Predictive markers | Sequential therapy | Overall survival | Targeted therapy | mRCC | Life Sciences & Biomedicine | Oncology | Science & Technology | Bevacizumab - therapeutic use | Humans | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Kidney Neoplasms - metabolism | Vascular Endothelial Growth Factor A - genetics | Sunitinib | Biomarkers, Tumor - metabolism | Axitinib | Imidazoles - therapeutic use | DNA-Binding Proteins | Receptors, CCR4 - genetics | Niacinamide - therapeutic use | Ubiquitin Thiolesterase - genetics | Carcinoma, Renal Cell - metabolism | Nivolumab | Sorafenib | Indoles - therapeutic use | MicroRNAs - genetics | Mutation | Indazoles - therapeutic use | Niacinamide - analogs & derivatives | Anilides - therapeutic use | Kidney Neoplasms - genetics | Prognosis | Gene Expression Regulation, Neoplastic | Carcinoma, Renal Cell - genetics | Tumor Suppressor Proteins - genetics | Everolimus - therapeutic use | Von Hippel-Lindau Tumor Suppressor Protein - genetics | Carcinoma, Renal Cell - drug therapy | Nuclear Proteins - genetics | Pyrroles - therapeutic use | Molecular Targeted Therapy - methods | Pyridines - therapeutic use | Histone-Lysine N-Methyltransferase - genetics | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Interferon-alpha - therapeutic use | Phenylurea Compounds - therapeutic use | Transcription Factors - genetics | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Carcinoma, Renal Cell - secondary | Kidney Neoplasms - pathology | Quinolines - therapeutic use | Kidney Neoplasms - drug therapy | Precision Medicine - methods | Immunologic Factors - therapeutic use | Antimitotic agents | Care and treatment | Metastasis | Antineoplastic agents | Patient outcomes | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights